Archives: Seminars

The stunning success of tobacco control rests on two pillars:  unimpeachable scientific evidence about the harm caused by inhaling (either directly or passively) combustible tobacco smoke, and damning evidence of the duplicity of the tobacco industry.   Today, the controversy over the use of tobacco harm reduction devices threatens those pillars.   In their zeal to protect… Read more »

In this session Dr Jasjit S. Ahluwalia reflects on the broader issues surrounding the science and evidence on e-cigarettes and tobacco harm reduction.  With thoughtful consideration, he will discuss the available health evidence on pulmonary, cardio vascular and cancer and consider this in context of all users and product evolution and safety.  He will ask:… Read more »

The presentation will consider what needs to happen for less risky alternatives to kill off smoking. It will include some thoughts on what motivates efforts by activists and regulators that are preventing smokers from switching to less harmful options; and provide a review of some of the developments that are improving the competitiveness of less… Read more »

The scientific agenda for research on reduced risk tobacco products remains splintered and counterproductive. This is because stakeholders have different goals in mind for what research ought to be able to demonstrate and which positions it should support. Tobacco and nicotine companies, naturally, hope to demonstrate that new, alternative products, compared to cigarettes or other… Read more »